MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, Msi2 is elevated ∼10-fold during the more aggressive blast crisis phase than in the chronic phase, and elevated Msi2 expression in CML has been linked to relapse and poorer prognosis [10].